Given the complexity of T cells, and considering that the impact of aging on T cell responsiveness is different among various T-cell subsets [33], it is crucial to define how T subset responses (CD4 and CD8 T cells) in the aging process promote or inhibit prostate cancer. This evidence concerns the gene CD4 and prostate carcinoma.